NDA/BLA filedconf 0.95

aficamten — NDA/BLA filed

$CYTK · CYTOKINETICS INC · obstructive hypertrophic cardiomyopathy (oHCM)

Event date

Date TBD

Sponsor runway

3 mo

$129.8M liquid

Evidence

“Cytokinetics submitted the NDA for aficamten in oHCM without an accompanying REMS, and the FDA accepted the NDA for filing.”

Source: 8-K filed 2025-05-01View on EDGAR ↗0000950170-25-061847

Comparable historical nda/bla fileds· last 5 years · same event type

Ticker	Drug	Date	Outcome
$AXSM	—	2025-12-31	unknown
$RCKT	kresladi	2025-10-14	unknown
$ALDX	reproxalap	2025-07-17	unknown
$ETON	et-600	2025-07-08	unknown
$BCRX	orladeyo (berotralstat)	2025-05-14	unknown
$CORT	relacorilant	2025-03-03	unknown
$ALDX	reproxalap	2024-11-01	unknown
$AXSM	axs-07	2024-09-04	unknown
$RCKT	kresladi	2023-10-02	unknown
$GERN	imetelstat	2023-08-21	unknown

Recent insider activity· ±90 days

6 insiders · 0 buys · 10 sells

Exercise10b5-1

2026-05-19

Malik Fady Ibraham

EVP Research & Development

3,500 @ $7.80$27K

Sell10b5-1

2026-05-19

Malik Fady Ibraham

EVP Research & Development

3,500 @ $75.69$265K

Sell10b5-1

2026-05-14

Blum Robert I

President & CEO

7,500 @ $77.92$584K

Sell10b5-1

2026-05-05

Lee Sung

EVP, Chief Financial Officer

23,906 @ $76.87$1.84M

Exercise10b5-1

2026-05-05

HENDERSON JOHN T

Director

20,000 @ $7.61$152K

Sell10b5-1

2026-05-05

HENDERSON JOHN T

Director

20,000 @ $75.97$1.52M

Exercise10b5-1

2026-05-05

WIERENGA WENDELL

Director

4,032 @ $12.40$50K

Sell10b5-1

2026-05-05

WIERENGA WENDELL

Director

4,032 @ $75.00$302K

Exercise10b5-1

2026-05-05

Malik Fady Ibraham

EVP Research & Development

3,500 @ $7.80$27K

Exercise10b5-1

2026-05-05

Callos Andrew

EVP, Chief Commercial Officer

11,333 @ $39.13$443K

Sell10b5-1

2026-05-05

Callos Andrew

EVP, Chief Commercial Officer

11,333 @ $77.25$875K

Sell10b5-1

2026-05-05

Malik Fady Ibraham

EVP Research & Development

3,500 @ $77.37$271K

Exercise10b5-1

2026-05-01

Callos Andrew

EVP, Chief Commercial Officer

15,857 @ $37.63$597K

Sell10b5-1

2026-05-01

Callos Andrew

EVP, Chief Commercial Officer

15,857 @ $65.00$1.03M

Exercise10b5-1

2026-04-30

Callos Andrew

EVP, Chief Commercial Officer

15,000 @ $23.26$349K

Sell10b5-1

2026-04-30

Callos Andrew

EVP, Chief Commercial Officer

15,000 @ $63.26$949K

Sell10b5-1

2026-04-29

Blum Robert I

President & CEO

7,500 @ $59.62$447K

Date	Insider	Action	Shares	Price	Value
2026-05-19	Malik Fady IbrahamEVP Research & Development	Exercise10b5-1	3,500	$7.80	$27K
2026-05-19	Malik Fady IbrahamEVP Research & Development	Sell10b5-1	3,500	$75.69	$265K
2026-05-14	Blum Robert IPresident & CEO	Sell10b5-1	7,500	$77.92	$584K
2026-05-05	Lee SungEVP, Chief Financial Officer	Sell10b5-1	23,906	$76.87	$1.84M
2026-05-05	HENDERSON JOHN TDirector	Exercise10b5-1	20,000	$7.61	$152K
2026-05-05	HENDERSON JOHN TDirector	Sell10b5-1	20,000	$75.97	$1.52M
2026-05-05	WIERENGA WENDELLDirector	Exercise10b5-1	4,032	$12.40	$50K
2026-05-05	WIERENGA WENDELLDirector	Sell10b5-1	4,032	$75.00	$302K
2026-05-05	Malik Fady IbrahamEVP Research & Development	Exercise10b5-1	3,500	$7.80	$27K
2026-05-05	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	11,333	$39.13	$443K
2026-05-05	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	11,333	$77.25	$875K
2026-05-05	Malik Fady IbrahamEVP Research & Development	Sell10b5-1	3,500	$77.37	$271K
2026-05-01	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	15,857	$37.63	$597K
2026-05-01	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	15,857	$65.00	$1.03M
2026-04-30	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	15,000	$23.26	$349K
2026-04-30	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	15,000	$63.26	$949K
2026-04-29	Blum Robert IPresident & CEO	Sell10b5-1	7,500	$59.62	$447K

← All catalysts for $CYTK